{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T22:54:12Z","timestamp":1784415252598,"version":"3.55.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3259,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1111\/j.1365-2133.2006.07536.x","type":"journal-article","created":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T15:01:53Z","timestamp":1159542113000},"page":"32-37","source":"Crossref","is-referenced-by-count":46,"title":["The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Beh\u00e7et disease"],"prefix":"10.1093","volume":"156","author":[{"given":"O.","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Ay El-Deen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"El Hadidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.D.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"El Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Abdel Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,9,29]]},"reference":[{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10238-004-0033-4","article-title":"Beh\u00e7et's disease","volume":"4","author":"Suzuki","year":"2004","journal-title":"Clin Exp Med"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00002281-199901000-00009","article-title":"Beh\u00e7et's syndrome","volume":"11","author":"Yazici","year":"1999","journal-title":"Curr Opin Rheumatol"},{"issue":"4 Suppl. 34","key":"10.1111\/j.1365-2133.2006.07536.x-BIB3|cit3","first-page":"S59","article-title":"T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Beh\u00e7et's disease","volume":"22","author":"Kibaroglu","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1067\/mjd.2001.117728","article-title":"HSP 60 expression in mucocutaneous lesions of Beh\u00e7et's disease","volume":"45","author":"Ergun","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/mp.55.4.209","article-title":"Chaperonins in disease: mechanisms, models, and treatments","volume":"55","author":"Ranford","year":"2002","journal-title":"Mol Pathol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB6|cit6","first-page":"708","article-title":"T cell responses to 60\/65\u2003kDa heat shock protein derived peptides in Turkish patients with Beh\u00e7et's disease","volume":"27","author":"Direskeneli","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1074\/jbc.271.13.7788","article-title":"The carboxy-terminal domain of vascular endothelial growth factor is critical for its mitogenic potency","volume":"271","author":"Keyt","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/cyto.1997.0297","article-title":"Activated human neutrophils express vascular endothelial growth factor","volume":"10","author":"Webb","year":"1998","journal-title":"Cytokine"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1365-4362.2003.01688.x","article-title":"Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Beh\u00e7et's syndrome","volume":"42","author":"Cekmen","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/1523-1747.ep12312542","article-title":"Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells","volume":"105","author":"Detmar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3349\/ymj.1991.32.4.326","article-title":"Absence of lupus anticoagulants in Beh\u00e7et's disease","volume":"32","author":"Bang","year":"1991","journal-title":"Yonsei Med J"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB12|cit12","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease","volume":"335","author":"Anonymous","year":"1990","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1067\/mjd.2002.118338","article-title":"Increased nitric oxide production in patients with Beh\u00e7et's disease: is it a new activity marker?","volume":"46","author":"Evereklioglu","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000018061","article-title":"Decreased nitric oxide production in patients with Beh\u00e7et's disease","volume":"198","author":"Orem","year":"1999","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB15|cit15","volume-title":"Clinical Epidemiology and Biostatistics","author":"Knapp","year":"1992"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2249.2005.02695.x","article-title":"Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Beh\u00e7et's disease","volume":"139","author":"Imamura","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N","article-title":"Experimental mucosal induction of uveitis with 60-kDa heat shock protein-derived peptide 336-351","volume":"28","author":"Hu","year":"1998","journal-title":"Eur J Immunol"},{"issue":"4 Suppl. 30","key":"10.1111\/j.1365-2133.2006.07536.x-BIB18|cit18","first-page":"S44","article-title":"The role of heat shock proteins in Beh\u00e7et's disease","volume":"21","author":"Direskeneli","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3349\/ymj.1997.38.6.350","article-title":"Etiopathology of Beh\u00e7et's disease: immunological aspects","volume":"38","author":"Sakane","year":"1997","journal-title":"Yonsei Medical J"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1074\/jbc.271.13.7788","article-title":"The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency","volume":"271","author":"Keyt","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/rheumatology\/keh281","article-title":"VEGF gene polymorphisms and susceptibility to rheumatoid arthritis","volume":"43","author":"Han","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","article-title":"Vascular endothelial function and oxidative stress mechanisms in patients with Beh\u00e7et's syndrome","volume":"37","author":"Chambers","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"H2357","DOI":"10.1152\/ajpheart.2001.280.5.H2357","article-title":"Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release","volume":"280","author":"Cho","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-\u03b1, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et's disease","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9440(10)65601-5","article-title":"Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate and the inducible nitric oxide synthase pathway","volume":"153","author":"Xiong","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2004-04-1519","article-title":"Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosis","volume":"105","author":"Matsushita","year":"2005","journal-title":"Blood"},{"issue":"4 Suppl. 38","key":"10.1111\/j.1365-2133.2006.07536.x-BIB27|cit27","first-page":"S42","article-title":"Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Beh\u00e7et's patients with venous thrombosis","volume":"23","author":"Bozoglu","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1468-3083.2003.t01-1-00574.x","article-title":"Nitric oxide levels in Beh\u00e7et's disease","volume":"17","author":"Sancak","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(97)00299-5","article-title":"Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events","volume":"89","author":"Hughes","year":"1998","journal-title":"Thromb Res"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00296-001-0157-8","article-title":"Clinical features of Beh\u00e7et's disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies?","volume":"21","author":"El-Ageb","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB31|cit31","first-page":"29","article-title":"Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases","volume":"118","author":"Ermakova","year":"2002","journal-title":"Vestn Oftalmol"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3346\/jkms.1998.13.4.400","article-title":"Anticardiolipin and anti-\u03b22-glycoprotein I antibodies in Beh\u00e7et's disease","volume":"13","author":"Kang","year":"1998","journal-title":"J Korean Med Sci"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/rheumatology\/40.2.192","article-title":"Anticardiolipin antibodies in Beh\u00e7et's disease: a reassessment","volume":"40","author":"Tokay","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1191\/961203303lu398oa","article-title":"Probing antiphospholipid mediated thrombosis: the interplay between anticardiolipin and endothelial cells","volume":"12","author":"Pierangli","year":"2003","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2006.07536.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0037-1614108","article-title":"Systemic endothelial cell markers in primary antiphospholipid syndrome","volume":"84","author":"Williams","year":"2000","journal-title":"Thromb Haemost"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07536.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2006.07536.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:19:02Z","timestamp":1676384342000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/156\/1\/32\/6643047"}},"subtitle":["Role of HSP60, VEGF and APA in Beh\u00e7et disease"],"short-title":[],"issued":{"date-parts":[[2006,9,29]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07536.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9,29]]}}}